Patents by Inventor Alya Khan

Alya Khan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210093575
    Abstract: The present invention provides a solid immediate release dosage form adapted for oral administration of GHB. The solid immediate release dosage form includes an immediate release formulation comprising a relatively high weight-percentage of GHB with a bioavailability similar to that of a liquid GHB dosage form.
    Type: Application
    Filed: October 9, 2020
    Publication date: April 1, 2021
    Inventors: Andrea ROURKE, Maura Patricia MURPHY, James Frederick PFEIFFER, Clark Patrick ALLPHIN, Alya Khan McGINLAY
  • Patent number: 8778398
    Abstract: The present invention provides a solid immediate release dosage form adapted for oral administration of GHB. The solid immediate release dosage form includes an immediate release formulation comprising a relatively high weight-percentage of GHB with a bioavailability similar to that of a liquid GHB dosage form.
    Type: Grant
    Filed: May 4, 2010
    Date of Patent: July 15, 2014
    Assignee: Jazz Pharmaceuticals, Inc.
    Inventors: Andrea Marie Rourke, Maura Patricia Murphy, James Frederick Pfeiffer, Clark Patrick Allphin, Alya Khan McGinlay
  • Publication number: 20110111027
    Abstract: The present invention provides a solid immediate release dosage form adapted for oral administration of GHB. The solid immediate release dosage form includes an immediate release formulation comprising a relatively high weight-percentage of GHB with a bioavailability similar to that of a liquid GHB dosage form.
    Type: Application
    Filed: May 4, 2010
    Publication date: May 12, 2011
    Applicant: JAZZ PHARMACEUTICALS, INC.
    Inventors: ANDREA MARIE ROURKE, MAURA PATRICIA MURPHY, JAMES FREDERICK PFEIFFER, CLARK PATRICK ALLPHIN, ALYA KHAN MCGINLAY
  • Publication number: 20050175696
    Abstract: A drug formulation is disclosed comprising granules having a substrate and a coating, said granule substrate comprising a solubilizing surfactant or a low solubility therapeutic drug, or both, and said granule coating comprising a hydrophilic polymer. Also disclosed is a drug formulation consisting of a tablet core made by mechanical compression, wherein said tablet core comprises granules having a substrate and a coating, said granule substrate comprising a solubilizing surfactant or a low solubility therapeutic drug, or both, and said granule coating comprising a hydrophilic polymer. Also disclosed is a dosage form for oral administration of topiramate, comprising a tablet core and an osmotic delivery system. Methods for controlling topiramate release patterns by altering the composition of the topiramate dosage form are also disclosed.
    Type: Application
    Filed: December 28, 2004
    Publication date: August 11, 2005
    Inventors: David Edgren, Alya Khan, Abdul Qureshi, James Ergun, Satishkumar Ramachandran, Noymi Yam